CADTH Canadian Drug Expert Committee recommendation. indication: the topical treatment of impetigo in patients aged two months and older. Ozenoxacin 1% cream (Ozanex -- Ferrer Internacional, S.A.) :

The CADTH Canadian Drug Expert Committee (CDEC) recommends that ozenoxacin not be reimbursed for the treatment of impetigo.

Saved in:

Bibliographic Details
Online Access:	Full text
Corporate Author:	CADTH Canadian Drug Expert Committee (Author)
Format:	Electronic eBook
Language:	English
Published:	Ottawa (ON) : Canadian Agency for Drugs and Technologies in Health, 2018
Edition:	Version: Final.
Series:	Common drug review clinical review report.
Subjects:	Impetigo > drug therapy. Child. Infant. Aminopyridines > therapeutic use. Quinolones > therapeutic use. Treatment Outcome. Cost-Benefit Analysis. Insurance, Health, Reimbursement. Children. Family members. Canada.

Internet

Full text